03/17/2025
3:57 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
7:36 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
8:10 AM | Rock Springs Capital Management LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:27 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:28 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:30 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:22 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:23 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:25 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
6:46 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025
6:47 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for TVTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/12/2025
10:03 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025
8:52 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025
10:56 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025
6:05 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
5:04 PM | Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
6:44 AM | MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
7:30 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:30 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:30 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:30 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:30 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:30 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:30 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
7:40 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
7:41 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
7:46 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
7:47 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
11:26 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
10:11 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
10:22 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
9:09 AM | Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/23/2025
7:35 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:36 PM | Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:37 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:39 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:40 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:31 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:33 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:14 PM | Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
01/22/2025
9:34 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
9:18 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
8:36 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:30 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
6:21 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:47 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:13 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
8:00 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:59 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:46 AM | Deep Track Capital, LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
3:55 PM | MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
3:11 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 424B5 | |
11/04/2024
12:55 PM | Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
7:36 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
7:41 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 424B5 | |
10/31/2024
7:05 AM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
10:59 AM | STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024
6:15 PM | LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
7:38 PM | Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:22 PM | Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
5:29 PM | Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:05 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:20 PM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
9:54 AM | REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
9:34 AM | Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
9:35 AM | ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
8:30 PM | Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:24 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form S-3ASR | |
08/01/2024
3:40 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
3:46 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
3:35 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form ARS | |
03/27/2024
3:31 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
3:31 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
3:33 PM | Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
| Form DEFA14A | |
